DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sautto GA, Wisskirchen K, Clementi N. , et al.
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.
Gut 2016;
65 (03) 512-523
We do not assume any responsibility for the contents of the web pages of other providers.